Burns Matteson Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Burns Matteson Capital Management's ELV Position: Q2 2026 in Review
Burns Matteson Capital Management increased its Elevance Health (ELV) stake by 7% in Q2 2026, buying an estimated $43.4K and bringing the position to 1,785 shares worth $690K. The position accounts for 0.22% of the portfolio, ranked #73.
Burns Matteson Capital Management first reported a position in ELV in Q2 2021 and has held it in 10 quarters since. The position peaked at $744K in Q4 2021. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Burns Matteson Capital Management held 1,785 shares of Elevance Health worth $690K as of Q2 2026.
- Burns Matteson Capital Management bought 117 Elevance Health shares in Q2 2026, an estimated $43.4K.
- Elevance Health made up 0.22% of Burns Matteson Capital Management's portfolio in Q2 2026, its #73 holding.
- Burns Matteson Capital Management first reported a position in Elevance Health in Q2 2021 and has held it in 10 quarters since.
- Burns Matteson Capital Management's Elevance Health position peaked at $744K in Q4 2021.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.